Orgenesis Debt to Equity Ratio Trends

Orgenesis Inc (ORGS)

0.5071 0.00 (0.00%) USD | NASDAQ | Apr 26, 16:00

0.50 -0.01 (-1.40%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-1.062
September 30, 2023	1.723
June 30, 2023	0.842
March 31, 2023	0.7086
December 31, 2022	0.6475
September 30, 2022	0.9152
June 30, 2022	0.6145
March 31, 2022	0.3141
December 31, 2021	0.279
September 30, 2021	0.2704
June 30, 2021	0.2215
March 31, 2021	0.2092
December 31, 2020	0.2153
September 30, 2020	0.1257
June 30, 2020	0.1208
March 31, 2020	0.1247
December 31, 2019	2.364
September 30, 2019	1.031

Date	Value
June 30, 2019	0.6687
March 31, 2019	0.1813
November 30, 2018	0.1314
August 31, 2018	0.0952
May 31, 2018	0.1099
February 28, 2018	0.2323
November 30, 2017	0.5446
August 31, 2017	0.7116
May 31, 2017	0.774
February 28, 2017	1.830
November 30, 2016	0.7875
August 31, 2016	0.6424
May 31, 2016	0.5037
February 29, 2016	0.4523
November 30, 2015	-1.596
August 31, 2015	-1.699
May 31, 2015	-1.837

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

-1.062

Minimum

Dec 2023

2.364

Maximum

Dec 2019

0.5439

Average

0.3141

Median

Mar 2022

Debt to Equity Ratio Benchmarks

Altimmune Inc	0.00
Verastem Inc	--
Oragenics Inc	--
Actinium Pharmaceuticals Inc	0.00
Dare Bioscience Inc	0.00

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	14.55M
Total Liabilities (Quarterly)	35.54M
Shareholders Equity (Quarterly)	-20.98M
Current Ratio	0.2484
Net Debt Paydown Yield	6.72%